Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in rats
about
Reversibility and heritability of liver fibrosis: Implications for research and therapyIncreased ADAMTS-13 proteolytic activity in rat hepatic stellate cells upon activation in vitro and in vivoCorrelation between TIMP-1 expression and liver fibrosis in two rat liver fibrosis models.Inhibition of phosphatidylinositol 3-kinase signaling in hepatic stellate cells blocks the progression of hepatic fibrosisIdentification and validation of genes involved in gastric tumorigenesis.Pathobiology of liver fibrosis: a translational success storyMutant MMP-9 and HGF gene transfer enhance resolution of CCl4-induced liver fibrosis in rats: role of ASH1 and EZH2 methyltransferases repressionCystamine ameliorates liver fibrosis induced by carbon tetrachloride via inhibition of tissue transglutaminase.Tumor necrosis factor-α promotes cholestasis-induced liver fibrosis in the mouse through tissue inhibitor of metalloproteinase-1 production in hepatic stellate cells.Plasminogen activator inhibitor-1 deficient mice are protected from angiotensin II-induced fibrosisBone marrow-derived mesenchymal stem cells protect against experimental liver fibrosis in ratsTissue inhibitor of metalloproteinase 1 (TIMP-1) deficiency exacerbates carbon tetrachloride-induced liver injury and fibrosis in mice: involvement of hepatocyte STAT3 in TIMP-1 productionAdiponectin reduces hepatic stellate cell migration by promoting tissue inhibitor of metalloproteinase-1 (TIMP-1) secretion.Simultaneous application of bevacizumab and anti-CTGF antibody effectively suppresses proangiogenic and profibrotic factors in human RPE cellsModels of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ.Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice.Deletion of Wntless in myeloid cells exacerbates liver fibrosis and the ductular reaction in chronic liver injury.The antifibrotic and fibrolytic properties of date fruit extract via modulation of genotoxicity, tissue-inhibitor of metalloproteinases and nuclear factor- kappa B pathway in a rat model of hepatotoxicityToll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice.Molecular pathogenesis of alcohol-induced hepatic fibrosis.Targeting the stromal microenvironment in chronic inflammation.Emerging therapies for liver fibrosis.Hepatic stellate cells and the reversal of fibrosis.Loss of steroid receptor co-activator-3 attenuates carbon tetrachloride-induced murine hepatic injury and fibrosis.Matrix metalloproteinase gene delivery for liver fibrosisFas Regulates Macrophage Polarization and Fibrogenic Phenotype in a Model of Chronic Ethanol-Induced Hepatocellular Injury.New role of plasminogen activator inhibitor-1 in alcohol-induced liver injury.TIMP-1/MMP-9 imbalance in brain edema in rats with fulminant hepatic failure.Effects of phased joint intervention on Rho/ROCK expression levels in patients with portal hypertensionAlcoholic liver disease and the potential role of plasminogen activator inhibitor-1 and fibrin metabolism.Advances in antifibrotic therapy.Reversal of hepatic fibrosis: pathophysiological basis of antifibrotic therapies.Reduction of hepatic fibrosis by overexpression of von Hippel-Lindau protein in experimental models of chronic liver diseaseModels and mechanisms of fibrosis resolution.Delivery and targeting of miRNAs for treating liver fibrosis.Curcumin targets multiple pathways to halt hepatic stellate cell activation: updated mechanisms in vitro and in vivo.Lack of kinin B₁ receptor potentiates leptin action in the liver.Current frontiers in systemic sclerosis pathogenesis.New therapies for hepatic fibrosis.The stellate cell system (vitamin A-storing cell system).
P2860
Q27026622-972E1BE1-F204-4B50-8DBC-2A3B90B562DCQ28584350-3119A383-EE7B-4E94-B1F9-BF374A9947C3Q34012945-44271F98-F7BC-4329-B682-6B888AB8C1C9Q34033114-4A92F112-AD88-4E83-81F0-7E53863AA5FEQ34419335-344CFD5A-AEA0-44F7-9436-B9D8EE564B44Q34462733-0057A5CA-CEA5-412B-8F68-8D73E27C696BQ34473076-D2BF86AE-0270-4A30-817A-B90ED8808FA3Q34606057-0918DB7E-6DBC-4CA5-8FDB-739A534A21D4Q34766246-12534999-0D16-4B17-A623-F83A2220F0B0Q34984527-CFBE56DA-CC6B-4AD6-B219-8BAA2DF5D143Q35045378-174D7C4B-6E25-4B7A-8A2D-1853926F404CQ35073951-BE8204B2-A90C-4A11-A214-6E342020DE93Q35126638-BCB261A3-1096-4B2E-ACD2-83924A16DFE2Q35359339-65B138BF-D3DE-4EE4-B8BD-04CBD7EB024AQ35649446-53FB027D-1CE6-489D-96F5-B6814678AA3DQ35760220-604A5B79-C9D8-48A2-A39D-EF6AC6C25AFDQ36163662-0C8D4944-FE6B-4D3C-9900-DBCC9467D7ACQ36173424-BAC63D85-EC27-47C3-A2AF-19858CD59D8BQ36243894-12D85962-9CAC-481A-A1C7-A14CF2BE1608Q36339556-B6DCA43C-ACEE-4600-BED5-4EE26D29BF8EQ36472008-44A4638C-514C-411F-9908-CE3ADEEF3E80Q36478124-1A438230-5726-4810-860D-D291BAEC8F2EQ36588244-1A39610C-7B68-4865-B058-E15B4DC7A5F6Q36749958-229F2CC4-52FC-4DF0-97A3-F42683BD6320Q36852793-881D9FA2-3E0E-49E7-A617-4CF48AD319A7Q36990218-EA5DE867-9EAB-4AE3-B4D9-4261159A6469Q37108878-88C17143-DF37-4053-90F2-BE8DA513BEB9Q37184471-5A59027E-2576-4C57-A9CF-425CF68FB3BBQ37204720-57D53383-2345-4332-98F8-D5604421B39DQ37305691-91898FEC-139D-466B-807F-218ABC20511FQ37353099-FA1A4047-2BAC-4241-986E-4E1B976413CDQ37355850-25439B8B-179F-4158-A303-612F5748CB81Q37598376-FC95B73C-CD63-408F-B2C7-33973D79BD62Q37834043-BAF9D2CC-0706-491C-8DA2-30A5BCFB4516Q38245905-A69F766B-616C-4BEF-A13B-B9B7BAFD2200Q38297265-62D252DF-23DB-40EB-806C-A774DB9FC602Q38317929-74A315FE-B26B-4EB7-AA36-50844E7C5C8EQ38364957-5FC5163F-87C5-4E8E-9EF1-B2DE615F2741Q38553309-D2F49770-E19F-4993-91FB-338C7A91FF4EQ38744473-4195C805-988E-4758-AD50-A7BE3F131273
P2860
Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in rats
description
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2004
@ast
im November 2004 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2004/11/01)
@sk
vědecký článek publikovaný v roce 2004
@cs
wetenschappelijk artikel (gepubliceerd op 2004/11/01)
@nl
наукова стаття, опублікована в листопаді 2004
@uk
مقالة علمية (نشرت في نوفمبر 2004)
@ar
name
Antifibrotic effects of a tiss ...... blished liver fibrosis in rats
@ast
Antifibrotic effects of a tiss ...... blished liver fibrosis in rats
@en
Antifibrotic effects of a tiss ...... blished liver fibrosis in rats
@nl
type
label
Antifibrotic effects of a tiss ...... blished liver fibrosis in rats
@ast
Antifibrotic effects of a tiss ...... blished liver fibrosis in rats
@en
Antifibrotic effects of a tiss ...... blished liver fibrosis in rats
@nl
prefLabel
Antifibrotic effects of a tiss ...... blished liver fibrosis in rats
@ast
Antifibrotic effects of a tiss ...... blished liver fibrosis in rats
@en
Antifibrotic effects of a tiss ...... blished liver fibrosis in rats
@nl
P2093
P3181
P356
P1433
P1476
Antifibrotic effects of a tiss ...... blished liver fibrosis in rats
@en
P2093
Adrian Tomkinson
Andreas Knorr
Baisong Mei
Barbara Krebs
Blair U. Bradford
Bodo Brocks
Christopher J. Parsons
Clark Q. Pan
Claudia Hirth-Dietrich
Ellen Cheung
P304
P3181
P356
10.1002/HEP.20425
P407
P577
2004-11-01T00:00:00Z